BioCentury
ARTICLE | Company News

Alza, Ribozyme deal

July 22, 1996 7:00 AM UTC

The companies will investigate the use of AZA's drug delivery technology to deliver ribozymes to treat central nervous system disorders. The companies will conduct cell culture and animal studies using local delivery of synthetic ribozymes via AZA's Alzet osmotic pumps. Alzet uses implantable, capsule-shaped units to deliver solutions at controlled rates. ...